Database will give BWH and Dana-Farber clinicians the ability to look at cancer outcomes at the hospitals and around the country.
Dr. Sandro Santagata explores the ancient cellular survival pathways co-opted by cancer.
A research team led by Karen Cichowski, PhD, and Thomas DeRaedt, PhD, BWH Division of Genetics,…
A study led by Christine G. Lian, MD, BWH Department of Pathology, suggests that the presence of…
The Cardio-Oncology Program, a joint collaboration between BWH and Dana-Farber Cancer Institute, focuses on the cardiovascular side effects of cancer therapy while maximizing cardiovascular outcomes for cancer survivors.
learned from studying HPV-associated cancers can also be applied to other tumor types
More than 60 multidisciplinary stakeholders develop recommendations to streamline the pathways for lung cancer care.
Raphael Bueno, MD performed the first successful iVATS case in the world earlier this year.
Researchers have transitioned Profile®, one of the nation’s most comprehensive personalized medicine initiatives in cancer.
Fill in your details below or click an icon to log in:
You are commenting using your WordPress.com account. ( Log Out / Change )
You are commenting using your Twitter account. ( Log Out / Change )
You are commenting using your Facebook account. ( Log Out / Change )
You are commenting using your Google+ account. ( Log Out / Change )
Connecting to %s
Notify me of new comments via email.
Basic HTML is allowed. Your email address will not be published.
Subscribe to this comment feed via RSS
Get every new post delivered to your Inbox.